Low serum concentrations of di-(2-ethylhexyl)phthalate in women with uterine fibromatosis

Gynecological Endocrinology

Volumn 22, Issue 2, 2006, Pages 92-95

  Luisi, Stefano ^a   Latini, Giuseppe ^b,c   De Felice, Claudio ^d   Sanseverino, Francesca ^a   Di Pasquale, Dorina ^e   Mazzeo, Pietro ^e   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b PERRINO HOSPITAL   (Italy)

^c CNR   (Italy)

^d Azienda Ospedaliera   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Di (2 ethylhexyl)phthalate; Environmental hazards; Monoethylhexylphthalate; Uterine fibromatosis

Indexed keywords

ETHYLHEXYLPHTHALATE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MENOPAUSE; NORMAL DISTRIBUTION; PRIORITY JOURNAL; UTERUS MYOMA;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLHEXYL PHTHALATE; FEMALE; HUMANS; LEIOMYOMA; MIDDLE AGED; PLASTICIZERS; RISK FACTORS; UTERINE NEOPLASMS;

EID: 33645775530     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600551312     Document Type: Article

References (21)

1. Blount BC, Milgram KE, Silva MJ, Malek NA, Reidy JA, Needham LL, Brock JW. Quantitative detection of eight phthalate metabolites in human urine using HPLC-APCI-MS/MS. Anal Chem 2000;72:4127-4134.
2. Latini G. The potential hazards of exposure to di-(2-ethylhexyl)- phthalate in babies: a review. Biol Neonate 2000;78:269-276.
3. Center for Devices and Radiological Health, US Food and Drug Administration (FDA). Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices [Internet]. Washington (DC): FDA, 2001 [cited 2001 Sep 5]. Available from: http://www.fda.gov/cdrh/ost/dehp-pvc.pdf
4. Tickner JA, Schettler T, Guidotti T, McCally M, Rossi M. Overview of patient health risks posed by the use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices. Am J Ind Med 2001;39:100-111.
5. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, Lucier GW, Jackson RJ, Brock JW. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 2000;108:972-982.
6. Center for the Evaluation of Risks to Human Reproduction. NTP-CERHR expert panel report on di(2-ethylhexyl) phthalate. Alexandria (VA): Science International, Inc.; 2000.
7. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P. Exposure to di-(2-ethylhexyl)phthalate in humans during pregnancy. A preliminary report. Biol Neonate 2003;83:22-24.
8. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P. In utero exposure to di-(2-ethylhexyl) phthalate and duration of human pregnancy. Environ Health Perspect 2003;111:1783-1785.
9. Hoyer PB. Reproductive toxicology: current and future directions. Biochem Pharmacol 2001;62,1557-1564.
10. Lovekamp-Swan T, Davis BJ. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect 2003;111:139-145.
11. Cobellis L, Latini G, De Felice C, Razzi S, Paris I, Ruggieri F, Mazzeo P, Petraglia F. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod 2003;18:1512-1515.
12. Greenberg MD, Kazamel TI. Medical and socioeconomic impact of uterine fibroids. Obstet Gynecol Clin North Am 1995;22:625-636.
13. Paris I, Ruggieri F, Mazzeo P, Carlucci G. Simultaneous determination of di(2-ethylhexyl)phthalate and mono(2-ethyl-hexyl)phthalate in human plasma by HPLC. Anal Lett 2003;36:2649-2658.
14. Gross KL, Panhuysen CI, Kleinman MS, Goldhammer H, Jones ES, Nassery N, Stewart EA, Morton CC. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer 2004;41:183-190.
15. Okubo T, Suzuki T, Yokoyama Y, Kano K, Kano I. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol Pharm Bull 2003;26:1219-1224.
16. Autian J. Toxicity and health threats of phthalate esters: review of the literature. Bethesda (MD): National Library of Medicine, Toxicology Information Response Center; 1972.
17. Hillman L, Goodwin S, Sherman W. Identification and measurement of plasticizer in neonatal tissues after umbilical catheters and blood products. N Engl J Med 1975;292:381-386.
18. Jaeger RJ, Rubin RJ. Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues. N Engl J Med 1972;287:1114-1118.
19. Aldyreva MV, Klimova TS, Iziumova AS, Timofeevskaia LA. The effect of phthalate plasticizers on the generative function. Gig Tr Prof Zabol 1975;19:25-29.
20. Tabacova S, Little R, Balabaeva L. Maternal exposure to phthalates and complications of pregnancy. Epidemiology 1999;10:S127.
21. Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000;108:895-900.